DiarioFarma. Ten years have passed since the launch of the first biosimilar to the market, a Sandoz somatropin, and Diariofarma wanted to analyze what has happened in this time, as well as the current vision of it with some of the protagonists of this historical event. Throughout the month of November, information and interviews will be published that analyze what has happened with biosimilars since 2006.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
